NL9401006A - Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. - Google Patents

Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. Download PDF

Info

Publication number
NL9401006A
NL9401006A NL9401006A NL9401006A NL9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A NL 9401006 A NL9401006 A NL 9401006A
Authority
NL
Netherlands
Prior art keywords
ibuprofen
treatment
salt
pharmaceutical composition
composition according
Prior art date
Application number
NL9401006A
Other languages
English (en)
Dutch (nl)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NL9401006A publication Critical patent/NL9401006A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL9401006A 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten. NL9401006A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
ITMI931324 1993-06-21

Publications (1)

Publication Number Publication Date
NL9401006A true NL9401006A (nl) 1995-01-16

Family

ID=11366435

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9401006A NL9401006A (nl) 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten.

Country Status (12)

Country Link
US (1) US5510385A (enExample)
JP (1) JPH0710749A (enExample)
BE (1) BE1007193A5 (enExample)
CA (1) CA2125644C (enExample)
CH (1) CH686866A5 (enExample)
DE (1) DE4420858A1 (enExample)
ES (1) ES2099022B1 (enExample)
FR (1) FR2706891B1 (enExample)
GB (1) GB2279251A (enExample)
IT (1) IT1264855B1 (enExample)
NL (1) NL9401006A (enExample)
SE (1) SE9402156L (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022967A1 (en) * 1994-02-24 1995-08-31 Otsuka Pharmaceutical Factory, Inc. Analgesic activity enhancer
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
MXPA04002973A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
KR101113005B1 (ko) 2003-03-21 2012-02-24 맥네일-피피씨, 인코포레이티드 비-스테로이드계 항염증성 약물 투여법
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
MXPA06014185A (es) * 2004-06-07 2007-04-16 Strides Arcolab Ltd Composicion farmaceutica que contiene una solucion estable y clara de medicamento anti-inflmatorio en capsulas de gelatina blanda, y proceso para producirlo.
US20050281876A1 (en) * 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
MX2009000145A (es) * 2006-06-30 2009-01-23 Mcneil Ppc Inc Capsulas duras llenas con liquido que contiene ibuprofeno.
BRPI0719021A2 (pt) 2006-11-21 2013-12-17 Mcneil-Ppc, Inc. Suspensões analgésicas de liberação modificada.
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
MX2010001789A (es) * 2007-08-15 2010-03-10 Mcneil Ppc Inc Regimen de dosificacion de ibuprofeno de liberacion inmediata y liberacion sostenida.
US8143314B1 (en) * 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101265178A (zh) * 2008-04-25 2008-09-17 北京阜康仁生物制药科技有限公司 一种右旋布洛芬的氨基酸盐及其药用组合物
CN108191846B (zh) * 2008-12-04 2021-08-20 于崇曦 高穿透性组合物及其应用
US20120101159A1 (en) * 2009-04-27 2012-04-26 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Ibuprofen lysinate oral suspension
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
PT2594266E (pt) * 2011-11-17 2014-11-03 Zambon Spa Composições farmacêuticas sólidas que contêm sais de ibuprofeno
HK1203162A1 (en) 2012-02-07 2015-10-23 麦克内尔-Ppc股份有限公司 Rapidly disintegrating coated tablets
EP2897646A1 (en) 2012-09-18 2015-07-29 McNeil-PPC, Inc. Sustained release oral dosage forms comprising low melting propionic acid derivative particles
WO2014047001A1 (en) 2012-09-18 2014-03-27 Mcneil-Ppc, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
WO2018017553A2 (en) 2016-07-19 2018-01-25 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CN109937034B (zh) 2016-11-21 2022-09-16 济世-伊沃泰克生物制品有限公司 阿柏西普制剂及其用途
MY202872A (en) 2017-11-20 2024-05-28 Just Evotec Biologics Inc Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
RU2020127753A (ru) 2018-01-22 2022-02-24 Джонсон энд Джонсон Консьюмер Инк. Перфорированные капсулы
SI3996699T1 (sl) 2019-07-09 2023-10-30 Farmalider, S. A. Kombinacija ibuprofena in tramadola za lajšanje bolečine
US20210378968A1 (en) 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
ATE128452T1 (de) * 1989-10-17 1995-10-15 Merck & Co Inc S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
ATE143805T1 (de) * 1991-03-22 1996-10-15 Merck & Co Inc Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations

Also Published As

Publication number Publication date
JPH0710749A (ja) 1995-01-13
GB2279251A (en) 1995-01-04
ES2099022B1 (es) 1998-01-16
FR2706891A1 (enExample) 1994-12-30
IT1264855B1 (it) 1996-10-17
CH686866A5 (it) 1996-07-31
CA2125644C (en) 2007-06-05
SE9402156D0 (sv) 1994-06-20
US5510385A (en) 1996-04-23
ITMI931324A0 (it) 1993-06-18
SE9402156L (sv) 1994-12-22
FR2706891B1 (enExample) 1995-10-20
DE4420858A1 (de) 1994-12-22
ITMI931324A1 (it) 1994-12-21
CA2125644A1 (en) 1994-12-22
BE1007193A5 (fr) 1995-04-18
GB9410987D0 (en) 1994-07-20
ES2099022A1 (es) 1997-05-01

Similar Documents

Publication Publication Date Title
US5510385A (en) Pharmaceutical compositions containing the salts of S(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
NL193307C (nl) Bruispreparaat met analgetische werkzaamheid.
KR950002150B1 (ko) 레보도파 메틸에스테르를 함유하는 제약 조성물
RU2652345C2 (ru) Кетопрофеновая композиция для местного применения
RU2218180C2 (ru) Комбинация анальгетиков
CZ290646B6 (cs) Parenterální farmaceutické kompozice
NL194390C (nl) Farmaceutische samenstelling die analgetische activiteit bezit met (s)- 2-(6-methoxy-2-naftyl)propionzuur en arginine.
Cattaneo et al. Clinical pharmacokinetics of ibuprofen arginine
NL9401005A (nl) Farmaceutische samenstelling met analgetische activiteit.
EP4661867A1 (en) Compositions comprising n,n-dimethyltryptamine, optionally in combination with n-acylethanolamines and uses thereof
CN109803953A (zh) 药物制剂及其用途
KR100567132B1 (ko) 이부프로펜과 아르기닌 함유 고농축 액상 조성물 및연질캡슐제
US4663345A (en) Etodolac for treatment of gout
KR100523242B1 (ko) 이부프로펜을 함유하는 정제 조성물
WO2024171073A1 (en) Compositions comprising 3,4-methylenedioxymethamphetamine, optionally in combination with n-acylethanolamines, and uses thereof
KR100986531B1 (ko) 액상의 아세클로페낙을 함유하는 캡슐제
WO2024171075A1 (en) Compositions comprising ibogaine, optionally in combination with n-acylethanolamines, and uses thereof
MXPA03012048A (es) Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
EP2965746B1 (en) An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
AU2008253125B2 (en) Oral dosage form providing fast absorption of drug
KR20240152875A (ko) L-트립토판, l-5-하이드록시트립토판 및 말초 분해 억제제를 포함하는 약학 조성물 및 약제
Lohare Ganesh et al. PERMEATION STUDIES OF NIMESULIDE FROM BUFFALO GHEE AS AN OLEAGINOUS BASE
AU2014200464A1 (en) Oral dosage form providing fast absorption of drug

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable